HomeATNM • NYSEAMERICAN
Actinium Pharmaceuticals Inc
add
$1.46
2.10%
After Hours:(0.00%)0.00
$1.46
Closed: Jun 18, 4:02:06 PM UTC-4 · USD · NYSEAMERICAN · Disclaimer
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 16.64M | 73.37% |
Net income | -15.94M | -83.83% |
Net profit margin | — | — |
Earnings per share | -0.51 | -64.52% |
EBITDA | -16.43M | -75.17% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 65.33M | -22.28% |
Total assets | 68.65M | -22.30% |
Total liabilities | 42.95M | -3.47% |
Total equity | 25.69M | — |
Shares outstanding | 31.20M | — |
Price to book | 1.74 | — |
Return on assets | -57.16% | — |
Return on capital | -135.36% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -15.94M | -83.83% |
Cash from operations | -7.57M | -2.71% |
Cash from investing | — | — |
Cash from financing | -2.00K | -100.01% |
Net change in cash | -7.58M | -202.61% |
Free cash flow | -1.90M | 58.63% |
Previous close
$1.43
Day range
$1.41 - $1.48
Year range
$1.03 - $8.64
Market cap
45.55M USD
Avg Volume
247.86K
P/E ratio
-
Dividend yield
-
About
CEO
Founded
2000
Website
Employees
31
